Paper2995303
Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits.
Perfect JR and 1 other. J Antimicrob Chemother, 1985. Cited by 95 papers, by iCite.
Cite this record
ConductScience Library. Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits. Papers, record 2995303. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2995303
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antifungal Agents | Major topic |
| Ketoconazole | Major topic |
| Meningitis, Haemophilus | Major topic |
| Triazoles | Major topic |
| Animals | |
| Fluconazole | |
| Itraconazole | |
| Rabbits |
Source PubMed
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 95 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41599210 | The Activity of FDA-Approved Prodrug Isavuconazonium Sulfate and Its Major Metabolite Isavuconazole Against Naegleria fowleri. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41599210 | PubMed |
| 39204295 | Approaches for Targeting Naegleria fowleri Using Nanoparticles and Artificial Peptides. | Pathogens | 2024 | https://conductscience.org/library/papers/39204295 | PubMed |
| 38085955 | Miconazole-like Scaffold is a Promising Lead for Naegleria fowleri-Specific CYP51 Inhibitors. | J Med Chem | 2023 | https://conductscience.org/library/papers/38085955 | PubMed |
| 31572393 | The Rise of Coccidioides: Forces Against the Dust Devil Unleashed. | Front Immunol | 2019 | https://conductscience.org/library/papers/31572393 | PubMed |
| 29284029 | CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM). | PLoS Negl Trop Dis | 2017 | https://conductscience.org/library/papers/29284029 | PubMed |
| 20430817 | Overexpression of TUF1 restores respiratory growth and fluconazole sensitivity to a Cryptococcus neoformans vad1Delta mutant. | Microbiology (Reading) | 2010 | https://conductscience.org/library/papers/20430817 | PubMed |
| 18171300 | The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates. | J Infect Dis | 2008 | https://conductscience.org/library/papers/18171300 | PubMed |
| 17178793 | Comparison of itraconazole and fluconazole treatments in a murine model of coccidioidal meningitis. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17178793 | PubMed |
| 15227171 | Systemic antifungal agents. | Tex Heart Inst J | 1990 | https://conductscience.org/library/papers/15227171 | PubMed |
| 11706924 | Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics. | Paediatr Drugs | 2001 | https://conductscience.org/library/papers/11706924 | PubMed |
| 10817701 | Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10817701 | PubMed |
| 10074549 | Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management. | J Clin Microbiol | 1999 | https://conductscience.org/library/papers/10074549 | PubMed |
| 9250423 | Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses. | Clin Pharmacokinet | 1997 | https://conductscience.org/library/papers/9250423 | PubMed |
| 8899853 | Fluconazole distribution to the brain: a crossover study in freely-moving rats using in vivo microdialysis. | Pharm Res | 1996 | https://conductscience.org/library/papers/8899853 | PubMed |
| 8557388 | Influence of serum protein binding on the in vitro activity of anti-fungal agents. | Infection | 1995 | https://conductscience.org/library/papers/8557388 | PubMed |
| 8448970 | Clinical pharmacokinetics of fluconazole. | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/8448970 | PubMed |
| 8261715 | Pharmacokinetic optimisation of oral antifungal therapy. | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/8261715 | PubMed |
| 7811028 | Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentrations in cerebrospinal fluid. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7811028 | PubMed |
| 7511361 | Effects of antifungal therapy on inflammation, sterilization, and histology in experimental Candida albicans meningitis. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7511361 | PubMed |
| 3280211 | Clinical pharmacokinetics of ketoconazole. | Clin Pharmacokinet | 1988 | https://conductscience.org/library/papers/3280211 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2995303
GET https://conductscience.org/api/papers/v1/2995303/cited_by?page=2